CVS Health beats earnings expectations but lowers profit forecast due to higher medical costs
From CNBC: 2024-08-07 06:41:45
CVS Health reported second-quarter earnings that exceeded expectations but lowered its full-year profit forecast due to higher medical costs impacting the U.S. insurance industry. Aetna President Brian Kane is leaving, with CEO Karen Lynch taking over management. CVS expects adjusted earnings of $6.40 to $6.65 per share, down from the previous guidance of at least $7 per share.
The company’s insurance division saw increased medical costs and negative effects from Medicare Advantage star ratings. Insurers like UnitedHealth Group and Humana have also faced rising costs due to more Medicare Advantage patients undergoing delayed procedures. Medicare Advantage covers over half of all Medicare beneficiaries, posing challenges for insurers.
In the second quarter, CVS reported adjusted earnings per share of $1.83, beating analyst expectations of $1.73 and posted revenue of $91.23 billion, slightly below the anticipated $91.5 billion. The healthcare company noted growth in its pharmacy business and insurance unit, while its health services segment faced a decline in sales.
CVS’s pharmacy benefit manager Caremark experienced decreased sales due to client price improvements and the loss of a major unnamed client. The company faces competition as clients like Tyson Foods and Blue Shield of California switched to other providers. The shifts reflect a broader trend in the healthcare industry towards transparency and cost reduction for patients.
CVS’ insurance segment generated over $32 billion in revenue in the second quarter, up more than 21% from the previous year. The division’s operating income fell slightly below analyst expectations, with a higher medical benefit ratio indicating increased medical expenses relative to premiums. The health services segment surpassed revenue estimates, processing over 470 million pharmacy claims during the quarter.
The pharmacy and consumer wellness division of CVS achieved over $29 billion in sales for the quarter, driven by increased prescription volume. However, factors like pharmacy reimbursement pressure and reduced front-store volume impacted sales. Despite challenges, CVS continues to operate over 9,000 retail pharmacies and offer various pharmacy services to its customers.
Read more at CNBC:: CVS Health (CVS) earnings Q2 2024